Literature DB >> 28094205

Legionnaires' disease at a medical center in southern Taiwan.

Tzu-Lun Hung1, Ming-Chi Li2, Li-Rong Wang3, Ching-Chuan Liu4, Chia-Wen Li2, Po-Lin Chen2, Ling-Shan Syue2, Nan-Yao Lee5, Wen-Chien Ko6.   

Abstract

BACKGROUND/
PURPOSE: Legionella pneumophila had been recognized as a pathogen for both healthcare-associated and community-acquired pneumonia. We aimed to evaluate clinical features and outcomes of patients with Legionnaires' disease at a tertiary medical center in southern Taiwan.
METHODS: From January 2005 to December 2013, a retrospective study of adult cases of Legionnaires' disease was conducted in a 1200-bed tertiary hospital. Their medical records were reviewed for further evaluation and analysis.
RESULTS: A total of 61 cases of Legionnaires' disease were identified during the study period. Their mean age was 61.1 years, with male predominance (43, 70.5%). Among them, 30 (49.2%) had healthcare-associated pneumonia (HCAP), 20 (32.8%) had community-acquired pneumonia, and notably 11 (18.0%) were caregivers. Patients with healthcare-associated pneumonia tend to have higher Charlson comorbidity scores than those with community-acquired pneumonia (3.6±2.4 vs. 1.9±1.9, p=0.008) and caregivers (0.5±0.5, p<0.001). Six patients died, resulting in an in-hospital mortality rate of 9.8%. Underlying cancer (66.7% vs. 20.0%, p=0.028) and a higher Charlson comorbidity score (4.7±2.6 vs. 2.2±2.2, p=0.013) were related to a fatal outcome.
CONCLUSION: L. pneumophila remains an important pathogen for pneumonia acquired from the community or associated with healthcare facility. Healthy caregivers may potentially be at risk for Legionella infection in certain clinical settings.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Legionnaires' disease; Taiwan; caregiver; pneumonia

Mesh:

Year:  2016        PMID: 28094205     DOI: 10.1016/j.jmii.2016.08.006

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  4 in total

1.  Investigation of a cluster of Legionnaires' disease during the outbreak of coronavirus disease 2019 pandemic in northeastern Taiwan, June 2021.

Authors:  Jung-Jr Ye; Jun-Yuan Zheng; Ya-Hsuan Chen; Ya-Ling Kao; Yu-Chin Kao; Shao-Wen Chao
Journal:  J Microbiol Immunol Infect       Date:  2022-05-05       Impact factor: 10.273

Review 2.  Legionnaires' Disease: Update on Diagnosis and Treatment.

Authors:  Diego Viasus; Valeria Gaia; Carolina Manzur-Barbur; Jordi Carratalà
Journal:  Infect Dis Ther       Date:  2022-05-03

3.  Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis.

Authors:  Annie S Jasper; Jackson S Musuuza; Jessica S Tischendorf; Vanessa W Stevens; Shantini D Gamage; Fauzia Osman; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2021-06-01       Impact factor: 20.999

4.  Legionnaires Disease Surveillance in US Department of Veterans Affairs Medical Facilities and Assessment of Health Care Facility Association.

Authors:  Shantini D Gamage; Meredith Ambrose; Stephen M Kralovic; Loretta A Simbartl; Gary A Roselle
Journal:  JAMA Netw Open       Date:  2018-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.